Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.

Ye JJ, Liang SJ, Guo N, Li SL, Wu AM, Giannini S, Sachdev D, Yee D, Brünner N, Ikle D, Fujita-Yamaguchi Y.

Horm Metab Res. 2003 Nov-Dec;35(11-12):836-42.

PMID:
14710366
[PubMed - indexed for MEDLINE]
2.

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.

Cancer Res. 2003 Feb 1;63(3):627-35.

PMID:
12566306
[PubMed - indexed for MEDLINE]
Free Article
3.

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.

Li SL, Liang SJ, Guo N, Wu AM, Fujita-Yamaguchi Y.

Cancer Immunol Immunother. 2000 Jul;49(4-5):243-52.

PMID:
10941907
[PubMed - indexed for MEDLINE]
4.

Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.

Chen J, Saggar JK, Corey P, Thompson LU.

Br J Nutr. 2011 Feb;105(3):339-47. doi: 10.1017/S0007114510003557. Epub 2010 Dec 7.

PMID:
21138602
[PubMed - indexed for MEDLINE]
5.

A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.

Goetsch L, Gonzalez A, Leger O, Beck A, Pauwels PJ, Haeuw JF, Corvaia N.

Int J Cancer. 2005 Jan 10;113(2):316-28.

PMID:
15386423
[PubMed - indexed for MEDLINE]
6.
7.

Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).

Brünner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ.

Eur J Cancer. 1993;29A(4):562-9.

PMID:
8435211
[PubMed - indexed for MEDLINE]
8.

Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.

Ohtani M, Numazaki M, Yajima Y, Fujita-Yamaguchi Y.

Biosci Trends. 2009 Aug;3(4):131-8.

PMID:
20103837
[PubMed - indexed for MEDLINE]
Free Article
9.

Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.

Chen J, Power KA, Mann J, Cheng A, Thompson LU.

Exp Biol Med (Maywood). 2007 Sep;232(8):1071-80.

PMID:
17720953
[PubMed - indexed for MEDLINE]
10.

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL.

Cancer Res. 2003 Dec 15;63(24):8912-21.

PMID:
14695208
[PubMed - indexed for MEDLINE]
Free Article
11.

Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.

Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.

Clin Cancer Res. 2000 May;6(5):2028-36.

PMID:
10815929
[PubMed - indexed for MEDLINE]
Free Article
12.

Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing 1H7 or 3B7 monoclonal antibody.

Kusada Y, Morizono T, Matsumoto-Takasaki A, Sakai K, Sato S, Asanuma H, Takayanagi A, Fujita-Yamaguchi Y.

J Biochem. 2008 Jan;143(1):9-19. Epub 2007 Oct 23.

PMID:
17956902
[PubMed - indexed for MEDLINE]
13.

Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.

Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.

Clin Cancer Res. 2006 Aug 1;12(15):4755-65.

PMID:
16899627
[PubMed - indexed for MEDLINE]
Free Article
15.

Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.

Wolf DM, Langan-Fahey SM, Parker CJ, McCague R, Jordan VC.

J Natl Cancer Inst. 1993 May 19;85(10):806-12.

PMID:
8487325
[PubMed - indexed for MEDLINE]
16.

The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer.

Brunner N, Spang-Thomsen M, Cullen K.

Breast Cancer Res Treat. 1996;39(1):87-92.

PMID:
8738608
[PubMed - indexed for MEDLINE]
17.

Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.

Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R.

Clin Cancer Res. 2007 Jul 15;13(14):4291-9.

PMID:
17634559
[PubMed - indexed for MEDLINE]
Free Article
18.

Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice.

Sacco SM, Power KA, Chen J, Ward WE, Thompson LU.

Exp Biol Med (Maywood). 2007 Jun;232(6):754-61.

PMID:
17526767
[PubMed - indexed for MEDLINE]
19.

Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft model.

Detre S, Riddler S, Salter J, A'Hern R, Dowsett M, Johnston SR.

Cancer Res. 2003 Oct 1;63(19):6516-22.

PMID:
14559845
[PubMed - indexed for MEDLINE]
Free Article
20.

Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.

Adam L, Crépin M, Isräel L.

Cancer Res. 1997 Mar 15;57(6):1023-9.

PMID:
9067263
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk